Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: Plasma soluble fas as a prognostic predictor in patients with congestive heart failure

Journal of Cardiac Failure

Volumn 7, Issue 4, 2001, Pages 322-328

  Tsutamoto, Takayoshi ^a   Wada, Atsuyuki ^a   Maeda, Keiko ^a   Mabuchi, Naoko ^a   Hayashi, Masaru ^a   Tsutsui, Takashi ^a   Ohnishi, Masato ^a   Fujii, Masanori ^a   Matsumoto, Takehiro ^a   Yamamoto, Takashi ^a   Takayama, Tomoyuki ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Apoptosis; Brain natriuretic peptide; Prognosis; Tumor necrosis factor

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; FAS ANTIGEN; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE CELL; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SOLUBILITY;

EID: 0035651790     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2001.30134     Document Type: Article

References (31)

1. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
2. Neurohormonal interactions and adaptations in congestive heart failure
3. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure
4. N-terminal proatrial natriuretic factor: An independent predictor of long-term prognosis after myocardial infarction
5. Prognostic value of plasma intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure
6. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
7. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
8. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
9. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1
10. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure
11. Apoptosis in myocytes in end-stage heart failure
12. Apoptosis in the failing human heart
13. Serum levels of soluble form of Fas molecule in patients with congestive heart failure
14. Increased circulating soluble form of Fas in patients with dilated cardiomyopathy
15. Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers
16. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
17. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure
18. Interleukin-6 spillover in peripheral circulation increases with the severity of heart failure and the high plasma interleukin-6 level is an important prognostic predictor of patients with congestive heart failure
19. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclasecoupled receptors
20. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes
21. Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism
22. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function
23. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure
24. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs
25. TNF-induced cardiomyopathy
26. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats
27. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart
28. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α
29. Peripartum cardiomyopathy: Analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-I
30. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
31. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction